Bristol Myers Squibb Director Julia Haller Exercises Options $1.10M

What Happened

• Julia A. Haller, a director of Bristol Myers Squibb (BMY), exercised stock options on 2026-06-15 to acquire 20,460 shares at an exercise price of $53.76 per share, representing a total value of about $1,099,930. The filing shows the options were exercised for cash and the underlying shares are being held.

Key Details

• Transaction date: 2026-06-15 (Form 4 filed 2026-06-16).
• Transaction code: M (exercise/conversion of derivative security).
• Shares acquired: 20,460 at $53.76 per share; total value ≈ $1,099,930.
• A second line reports the derivative (the option) as disposed at $0 — standard reporting when an option is converted into shares.
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — cash exercise and the reporting person is currently holding the underlying shares; F2 — all of the shares were exercisable.
• Timeliness: Filing was submitted one day after the transaction date (appears timely under Form 4 reporting rules).

Context

• This was an option exercise (not an immediate sale). The director converted/options into shares via a cash exercise and retained the shares, rather than selling them immediately. Such exercises can be routine (e.g., to convert vested options) and do not alone indicate the insider’s market view.